{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:26:52Z","timestamp":1787772412514,"version":"build-2784847793"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Trachyonychia is a benign nail condition, most commonly seen in children. Trachyonychia manifests as excessive longitudinal ridging, nail roughness, and nail brittleness. Treatment is sought mainly for esthetic reasons as well as functional reasons. A number of therapeutic approaches exist, mainly based on case reports or small non-comparative case series.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To report treatment outcome among patients with trachyonychia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective case-series study was conducted among patients who were treated trachyonychia between years 2017 and 2020. Patients were prescribed fluocinonide 0.05% with bifonazole 1% cream, applied with or without occlusion, and methylprednisolone 1\u20132 mg\/nail, injected into the involved nail matrix, or oral cyclosporine 3 mg\/kg. Complete response (over 90% improvement) and partial response (over 50% improvement) were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 43 patients with trachyonychia were included [mean age 10.0 years (\u00b15.7), 69.8% males, mean disease duration 4.7 years (\u00b13.0)]. In 90.7% of the cases, topical fluocinonide\\bifonazole cream was prescribed. Under-occlusion topical application was found to be highly effective, achieving complete response in 35.3% and partial response in an additional 52.9% of the patients. Occluded application was also found to be significantly more effective than non-occluded application. Treatment efficacy was not affected by the severity of nail roughness, trachyonychia morphology, or whether trachyonychia was idiopathic or coexisted with other dermatological conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Occluded application of fluocinonide plus bifonazole cream is efficient for the treatment of trachyonychia and should be considered a first line of treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_1088_21","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T12:15:14Z","timestamp":1716984914000},"page":"834","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Fluocinonide\\Bifonazole Cream for the Treatment of Trachyonychia"],"prefix":"10.4103","volume":"67","author":[{"given":"Avner","family":"Shemer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nechama","family":"Sharon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Farhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baruch","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vered","family":"Hermush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Galili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-67-20240829","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000445544","article-title":"Trachyonychia and twenty-nail dystrophy: A comprehensive review and discussion of diagnostic accuracy","volume":"2","author":"Jacobsen","year":"2016","journal-title":"Skin Appendage Disord"},{"key":"R2-67-20240829","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000449063","article-title":"Trachyonychia: Review and update on clinical aspects, histology, and therapy","volume":"2","author":"Haber","year":"2017","journal-title":"Skin Appendage Disord"},{"key":"R3-67-20240829","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/ced.12934","article-title":"Isolated recessive nail dysplasia caused by FZD6 mutations: Report of three families and review of the literature","volume":"41","author":"Kasparis","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"R4-67-20240829","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/pde.12427","article-title":"Long-term follow-up of pediatric trachyonychia","volume":"32","author":"Kumar","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"R5-67-20240829","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1440-0960.2006.00264.x","article-title":"Follow up of 12 patients with trachyonychia","volume":"47","author":"Sakata","year":"2006","journal-title":"Australas J Dermatol"},{"key":"R6-67-20240829","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/jdv.16186","article-title":"Trachyonychia: A retrospective study of 122 patients in a period of 30 years","volume":"34","author":"Starace","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R7-67-20240829","doi-asserted-by":"crossref","first-page":"371","DOI":"10.5021\/ad.2015.27.4.371","article-title":"Efficacy and safety of calcipotriol\/betamethasone dipropionate ointment for the treatment of trachyonychia: An open-label study","volume":"27","author":"Park","year":"2015","journal-title":"Ann Dermatol"},{"key":"R8-67-20240829","doi-asserted-by":"crossref","first-page":"608","DOI":"10.5021\/ad.2017.29.5.608","article-title":"Therapeutic efficacy of combination therapy using oral cyclosporine with a dietary supplement (Pantogar\u00ae) in twenty-nail dystrophy","volume":"29","author":"Oh","year":"2017","journal-title":"Ann Dermatol"},{"key":"R9-67-20240829","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1346-8138.2005.tb00882.x","article-title":"Efficacy of triamcinolone acetonide in various acquired nail dystrophies","volume":"32","author":"Grover","year":"2005","journal-title":"J Dermatol"},{"key":"R10-67-20240829","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1346-8138.2012.01642.x","article-title":"Cyclosporin administration improves clinical manifestations and quality of life in patients with 20-nail dystrophy: Case series and survey study","volume":"39","author":"Lee","year":"2012","journal-title":"J Dermatol"},{"key":"R11-67-20240829","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/jdv.15024","article-title":"Alitretinoin can be a good treatment option for idiopathic recalcitrant trachyonychia in adults: An open-label study","volume":"32","author":"Shin","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R12-67-20240829","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2230.2005.01737.x","article-title":"Treatment of trachyonychia with tazarotene","volume":"30","author":"Soda","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"R13-67-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000056328","article-title":"Effects of skin occlusion on percutaneous absorption: An overview","volume":"14","author":"Zhai","year":"2001","journal-title":"Skin Pharmacol Appl Skin Physiol"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_1088_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:45:15Z","timestamp":1787769915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_1088_21"}},"subtitle":["A Retrospective Case Series"],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_1088_21","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}